Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-015235

Executive Vice President gave up 255,109 shares (to pay taxes)

  • Executive Vice President acquired 508,499 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shah Nikita Executive Vice President 2026-03-03 Option exercise +36,232 182,635 D
Shah Nikita Executive Vice President 2026-03-03 Shares withheld for taxes −18,502 $13.31 $246,262 164,133 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise +45,871 210,004 D
Shah Nikita Executive Vice President 2026-03-03 Shares withheld for taxes −22,982 $13.31 $305,890 187,022 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise +23,544 210,566 D
Shah Nikita Executive Vice President 2026-03-03 Shares withheld for taxes −11,796 $13.31 $157,005 198,770 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise +366,972 565,742 D
Shah Nikita Executive Vice President 2026-03-03 Shares withheld for taxes −183,853 $13.31 $2,447,083 381,889 D
Shah Nikita Executive Vice President 2026-03-04 Option exercise +35,880 417,769 D
Shah Nikita Executive Vice President 2026-03-04 Shares withheld for taxes −17,976 $13.30 $239,081 399,793 D
Derivatives
Shah Nikita Executive Vice President 2026-03-03 Option exercise · Restricted Stock Units −36,232 0 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise · Restricted Stock Units −45,871 45,872 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise · Restricted Stock Units −23,544 70,634 D
Shah Nikita Executive Vice President 2026-03-03 Option exercise · Performance-Based Restricted Stock Units −366,972 0 D
Shah Nikita Executive Vice President 2026-03-04 Option exercise · Restricted Stock Units −35,880 71,760 D
Loading xslF345X05/wk-form4_1772746235.xml…